NO20054562D0 - Impregnert pulver som forbedrer biotilgjengelighet og/eller opploselighet og fremgangsmate for fremstilling derav - Google Patents
Impregnert pulver som forbedrer biotilgjengelighet og/eller opploselighet og fremgangsmate for fremstilling deravInfo
- Publication number
- NO20054562D0 NO20054562D0 NO20054562A NO20054562A NO20054562D0 NO 20054562 D0 NO20054562 D0 NO 20054562D0 NO 20054562 A NO20054562 A NO 20054562A NO 20054562 A NO20054562 A NO 20054562A NO 20054562 D0 NO20054562 D0 NO 20054562D0
- Authority
- NO
- Norway
- Prior art keywords
- solubility
- preparation
- impregnated powder
- improves bioavailability
- bioavailability
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
- Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
- Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
- Y10T428/2995—Silane, siloxane or silicone coating
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
- Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
- Y10T428/2996—Glass particles or spheres
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
- Y10T428/2998—Coated including synthetic resin or polymer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0302802A FR2851918B1 (fr) | 2003-03-06 | 2003-03-06 | Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication |
PCT/FR2004/000541 WO2004080381A2 (fr) | 2003-03-06 | 2004-03-05 | Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054562D0 true NO20054562D0 (no) | 2005-10-04 |
NO20054562L NO20054562L (no) | 2005-12-01 |
Family
ID=32865308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054562A NO20054562L (no) | 2003-03-06 | 2005-10-04 | Impregnert pulver som forbedrer biotilgjengelighet og/eller opploselighet og fremgangsmate for fremstilling derav |
Country Status (11)
Country | Link |
---|---|
US (1) | US7569274B2 (no) |
EP (1) | EP1603538A2 (no) |
JP (1) | JP4901469B2 (no) |
AU (1) | AU2004218859B2 (no) |
BR (1) | BRPI0408065A (no) |
CA (1) | CA2518200C (no) |
FR (1) | FR2851918B1 (no) |
MX (1) | MXPA05009440A (no) |
NO (1) | NO20054562L (no) |
RU (1) | RU2367412C2 (no) |
WO (1) | WO2004080381A2 (no) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY142989A (en) * | 2004-03-10 | 2011-02-14 | Bayer Schering Pharma Ag | Stabilised supersaturated solids of lipophilic drugs |
CA2598762A1 (en) * | 2005-02-25 | 2006-08-31 | F. Hoffmann-La Roche Ag | Tablets with improved drug substance dispersibility |
US8663681B2 (en) | 2005-05-26 | 2014-03-04 | Teva Women's Health, Inc. | Oral dosage forms comprising progesterone and methods of making and using the same |
RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
US20080160097A1 (en) * | 2006-12-28 | 2008-07-03 | Avon Products, Inc. | Method for imparting a cosmetic or therapeutic benefit to a topical surface and process for making |
ES2603617T3 (es) | 2007-02-23 | 2017-02-28 | Gilead Sciences, Inc. | Moduladores de propiedades farmacocinéticas de la terapéutica |
US20110097414A1 (en) * | 2007-02-26 | 2011-04-28 | Sandal Roshan Lal | Pharmaceutical compositions comprising adsorbate of fenofibrate |
CA2693269A1 (en) * | 2007-07-19 | 2009-01-22 | Luzenac America, Inc. | Silicone coatings, methods of making silicone coated articles and coated articles therefrom |
US10531681B2 (en) | 2008-04-25 | 2020-01-14 | Sensient Colors Llc | Heat-triggered colorants and methods of making and using the same |
KR101784647B1 (ko) * | 2008-05-02 | 2017-10-11 | 길리애드 사이언시즈, 인코포레이티드 | 제약 제제의 가공성 향상을 위한 고체 담체 입자의 용도 |
US20090298952A1 (en) * | 2008-05-07 | 2009-12-03 | Brimmer Karen S | Platable soluble dyes |
US9113647B2 (en) | 2008-08-29 | 2015-08-25 | Sensient Colors Llc | Flavored and edible colored waxes and methods for precision deposition on edible substrates |
US20100102142A1 (en) * | 2008-10-28 | 2010-04-29 | Daria Tagliareni | Scent dispenser assembly |
RU2448684C2 (ru) * | 2009-01-15 | 2012-04-27 | Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН "МНИИЭМ им. Г.Н. Габричевского" Роспотребнадзора) | Препарат, содержащий биологически активные действующие вещества |
KR100926952B1 (ko) | 2009-06-04 | 2009-11-17 | 화인케미칼 주식회사 | 고분자 컴파운드용 오일함유 파우더 |
US11052029B2 (en) * | 2009-06-16 | 2021-07-06 | W. R. Grace & Co.-Conn. | Cation compatible metal oxides and oral care compositions containing the metal oxides |
CN102770113A (zh) | 2009-12-29 | 2012-11-07 | 格雷斯公司 | 形成具有所需遮蔽度的膜的组合物及其制造和使用方法 |
RU2016101363A (ru) * | 2010-02-08 | 2018-11-21 | Прэари Фармасьютикалз, Ллк | Способ лечения заболеваний, связанных с глюкокортикоидной нечувствительностью |
US10987361B2 (en) | 2010-02-08 | 2021-04-27 | Shenzhen Evergreen Therapeutics Co., Ltd. | Treating auto-immune and auto-inflammatory diseases |
US10993879B2 (en) | 2010-02-08 | 2021-05-04 | Shenzhen Evergreen Therapeutics Co., Ltd. | Pulmonary delivery of progestogen |
US10004682B2 (en) | 2010-08-24 | 2018-06-26 | Rutgers, The State University Of New Jersey | Formulation and manufacture of pharmaceuticals by impregnation onto porous carriers |
AU2012307656B2 (en) * | 2011-09-15 | 2016-07-07 | Friulchem Spa | Compositions for oral administration to animals, production methods thereof and uses of same |
BR112014012444B1 (pt) | 2011-11-23 | 2021-12-14 | Therapeuticsmd, Inc | Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
JP2013169146A (ja) * | 2012-02-17 | 2013-09-02 | Kabaya Shokuhin Kk | 新規清涼菓子およびその製造方法 |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
JP6513031B2 (ja) | 2013-02-01 | 2019-05-15 | ダブリュー・アール・グレース・アンド・カンパニー−コーンW R Grace & Co−Conn | 液体テクノロジーのための担体としての多孔質シリカゲル |
HUE047749T2 (hu) | 2013-02-06 | 2020-05-28 | Hermes Arzneimittel Gmbh | Gyógyszereket alacsony dózisban tartalmazó gyógyászati készítmények |
JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然の併用ホルモン補充療法剤及び療法 |
DK3157506T3 (da) | 2014-06-20 | 2020-11-23 | Hermes Arzneimittel Gmbh | Smagsmaskeret oral, farmaceutisk sammensætning |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017081725A1 (ja) * | 2015-11-09 | 2017-05-18 | 花王株式会社 | 口腔用組成物 |
CN105456203B (zh) * | 2015-12-11 | 2018-05-15 | 中国人民解放军63975部队 | 一种药物-载体模式复合微粉制备方法 |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
EP3435977A4 (en) | 2016-04-01 | 2019-10-16 | Therapeuticsmd, Inc. | PHARMACEUTICAL COMPOSITION OF STEROID HORMONE |
KR102524880B1 (ko) * | 2017-12-21 | 2023-04-21 | 한양대학교 산학협력단 | 하이드로콜로이드 조성물 및 이를 포함하는 바이오 패치 |
CN109123285A (zh) * | 2018-08-27 | 2019-01-04 | 上海戚熊实业有限公司 | 一种太岁浸渍工艺制备的饮用水 |
CA3160750A1 (en) | 2019-12-09 | 2021-06-17 | Anthony Richard Gerardi | Oral product comprising a cannabinoid |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
WO2023214018A1 (en) | 2022-05-06 | 2023-11-09 | Galenix Innovations | Gastro-retentive swellable sustained release composition |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1468815A (en) * | 1973-10-18 | 1977-03-30 | Vymatt Sa | Pharmaceutical compositions |
GB8822857D0 (en) * | 1988-09-29 | 1988-11-02 | Patralan Ltd | Pharmaceutical formulations |
IT1291362B1 (it) * | 1997-05-13 | 1999-01-07 | Vectorpharma Int | Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi |
JP2000026283A (ja) * | 1998-07-10 | 2000-01-25 | Nisshin Oil Mills Ltd:The | 油性組成物を含有した粉末組成物 |
EP2127642A3 (en) * | 1998-08-13 | 2010-02-24 | Cima Labs, Inc. | Microemulsions as solid dosage forms for oral administration |
US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
AU2001241730B2 (en) * | 2001-02-23 | 2007-03-15 | Cima Labs Inc. | Emulsions as solid dosage forms for oral administration |
ITMI20011756A1 (it) * | 2001-08-09 | 2003-02-09 | Remedia S R L | Composizione farmaceutica comprendente una microemulsione doppia acqua/olio/acqua incorporata in un supporto solido |
ITMI20012694A1 (it) * | 2001-12-19 | 2003-06-19 | Remedia S R L | Composizione farmaceutica comprendente una microemulsione doppia olio/acqua/olio incorporata in un supporto solido |
-
2003
- 2003-03-06 FR FR0302802A patent/FR2851918B1/fr not_active Expired - Fee Related
-
2004
- 2004-03-05 EP EP04717669A patent/EP1603538A2/fr not_active Withdrawn
- 2004-03-05 CA CA2518200A patent/CA2518200C/fr not_active Expired - Fee Related
- 2004-03-05 MX MXPA05009440A patent/MXPA05009440A/es active IP Right Grant
- 2004-03-05 JP JP2006505704A patent/JP4901469B2/ja not_active Expired - Fee Related
- 2004-03-05 US US10/547,797 patent/US7569274B2/en not_active Expired - Fee Related
- 2004-03-05 BR BRPI0408065-3A patent/BRPI0408065A/pt not_active IP Right Cessation
- 2004-03-05 WO PCT/FR2004/000541 patent/WO2004080381A2/fr active Application Filing
- 2004-03-05 RU RU2005130989/15A patent/RU2367412C2/ru not_active IP Right Cessation
- 2004-03-05 AU AU2004218859A patent/AU2004218859B2/en not_active Ceased
-
2005
- 2005-10-04 NO NO20054562A patent/NO20054562L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2006519820A (ja) | 2006-08-31 |
WO2004080381A2 (fr) | 2004-09-23 |
NO20054562L (no) | 2005-12-01 |
AU2004218859A1 (en) | 2004-09-23 |
EP1603538A2 (fr) | 2005-12-14 |
RU2005130989A (ru) | 2006-08-10 |
AU2004218859B2 (en) | 2009-10-15 |
BRPI0408065A (pt) | 2006-02-14 |
MXPA05009440A (es) | 2006-04-07 |
CA2518200C (fr) | 2013-04-30 |
JP4901469B2 (ja) | 2012-03-21 |
FR2851918A1 (fr) | 2004-09-10 |
CA2518200A1 (fr) | 2004-09-23 |
US20060182691A1 (en) | 2006-08-17 |
WO2004080381A3 (fr) | 2005-07-28 |
FR2851918B1 (fr) | 2006-06-16 |
US7569274B2 (en) | 2009-08-04 |
RU2367412C2 (ru) | 2009-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054562D0 (no) | Impregnert pulver som forbedrer biotilgjengelighet og/eller opploselighet og fremgangsmate for fremstilling derav | |
IL247620B (en) | The composition and method of its creation for the preparation of helicondrin b | |
EP1841761A4 (en) | Fumagillol derivatives or processes for the preparation of fumagillol derivatives, and pharmaceutical compositions containing them | |
NO20054329D0 (no) | Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike | |
CR8226A (es) | Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos | |
DK2508521T4 (da) | Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf | |
IL175647A0 (en) | Composition and method for enhancing bioavailability | |
NO20042155L (no) | N-adamantylmetylderivater og mellomprodukter som farmasoytiske sammensetninger og fremgangsmater til deres fremstilling | |
HUE042590T2 (hu) | Eljárás kurkumin biológiai hasznosíthatóságának javítására | |
NO20054876D0 (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser | |
EP1878164A4 (en) | DEVICE AND METHOD PRESENTING THE AVAILABILITY OF WIRELESS LOCAL NETWORK | |
IL176515A0 (en) | 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same | |
EP1541165A4 (en) | METHOD FOR STABILIZING PROTEIN PREPARATION | |
GB0406635D0 (en) | Process for the preparation of an emulsion | |
ZA200606542B (en) | 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same | |
IL162844A0 (en) | Use of an expression vector for preparing pharmaceutical compositions | |
ITMI20041143A1 (it) | Polimorfi di fexofenadina e procedimento per la loro preparazione | |
NO20042890L (no) | Farmasoytiske preparater og fremgangsmate for fremstilling derav | |
EP1680398A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING THIOUREE DERIVATIVE AND HAVING IMPROVED SOLUBILITY AND BIODAVAILABILITY | |
EP1646640A4 (en) | PROCESS FOR PREPARING HIGH-PURITY 1-ANDROSTEN DERIVATIVES | |
IL165137A0 (en) | Process for the preparation of thioalkylamine derivatives | |
EP2147916A4 (en) | PROCESS FOR THE PREPARATION OF SYNTHETIC TAXANES | |
NO20044332L (no) | Forbedret fremgangsmate for fremstilling av nevirapine | |
ITMI20031994A1 (it) | Procedimento per la preparazione di fludarabina fosfato | |
ITFI20030033A1 (it) | Processo per la preparazione di derivati ribofuranosidici |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |